Company MELA Sciences Inc Nasdaq
Equities
US55277R1005
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermatology Recurring Procedures
64.5
%
| 23 | 63.7 % | 22 | 64.5 % | -6.49% |
Dermatology Procedures Equipment
35.5
%
| 13 | 36.3 % | 12 | 35.5 % | -9.96% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
69.0
%
| 24 | 66.3 % | 23 | 69.0 % | -3.97% |
Other Foreign
12.8
%
| 4 | 10.3 % | 4 | 12.8 % | +14.79% |
China
10.0
%
| 5 | 13.1 % | 3 | 10.0 % | -29.70% |
South Korea
8.2
%
| 4 | 10.3 % | 3 | 8.2 % | -26.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 09/04/18 |
Director of Finance/CFO | 42 | 05/07/21 | |
Shmuel Gov
COO | Chief Operating Officer | - | 31/12/14 |
Amandeep Kaur
SAM | Sales & Marketing | - | 12-03 |
Brent Cowgill
SAM | Sales & Marketing | - | 01/08/21 |
John Bagdasarian
PRN | Corporate Officer/Principal | - | 13/03/22 |
Jay Sturm
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 28/05/18 |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 09/04/18 |
Director/Board Member | 60 | 28/05/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,506,092 | 2,082,935 ( 59.41 %) | 0 | 59.41 % |
Company contact information
STRATA Skin Sciences, Inc.
5 Walnut Grove Drive Suite 140
19044, Horsham
+215 619 3200
http://www.strataskinsciences.com![address MELA Sciences Inc](https://cdn.zonebourse.com/static/address/9999.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+4.57% | 212B | |
+8.61% | 187B | |
+26.34% | 155B | |
+33.90% | 115B | |
+2.17% | 65.5B | |
+14.50% | 52.87B | |
-3.30% | 45.25B | |
-3.98% | 39.7B | |
+6.66% | 37.72B |
- Stock Market
- Equities
- SSKN Stock
- Stock
- Company MELA Sciences Inc